Where should I inject tirzepatide — and does it matter?

Which parts of the body are approved for tirzepatide injections?

The licensed sites for tirzepatide are the abdomen (belly), the front or outer thigh, and the outer upper arm. The NHS medicines guidance for tirzepatide confirms all three as suitable for subcutaneous injection, meaning just under the skin, not into muscle.

Within the abdomen, aim for the area around the navel but stay at least 5 cm away from it. The thigh site covers the front and outer surface of the upper leg; avoid the inner thigh and the area directly behind the knee. For the upper arm, the soft tissue on the outer side is the target, most people find this easier to reach with help from someone else, though some manage it independently.

There is no clinical reason to prefer one site over another in terms of how well the medicine works. What matters far more is the rotation pattern you keep across those three zones week after week, and our detailed guide to where to inject tirzepatide covers each approved location with practical advice on technique and rotation. You can find a more detailed breakdown of the thigh option specifically at our guide to thigh injections for tirzepatide.

Tirzepatide comes as a pre-filled KwikPen; the needle is short, fine and designed for subcutaneous use. There is no need to pinch the skin unless you are very lean, your prescriber or the Patient Information Leaflet supplied with your medication can clarify this for your situation.

Why does rotating the injection site actually matter?

Every injection causes a tiny amount of tissue disruption. Over time, repeated injections in exactly the same spot lead to lipohypertrophy, patches of thickened, fibrous tissue under the skin. These lumps are not dangerous in themselves, but injecting into them changes how the medicine is absorbed. Tirzepatide delivered through scarred tissue may be absorbed more slowly or unpredictably, which undermines the consistency the treatment depends on.

Rotating systematically (ideally moving around a mental clock face within each zone, and alternating between zones from week to week) prevents this. Some people keep a simple note on their phone logging which site they used and when. It is a small habit that protects the effectiveness of the treatment over the long term.

Bruised skin, active infection, skin conditions, or areas with stretch marks or scars should be avoided as injection sites regardless of which zone you're using. The full Mounjaro injection guide covers the step-by-step process alongside site selection, including how to prepare the skin and check your pen before injecting.

Can you inject tirzepatide in the same spot as last week?

The straightforward answer is: no, not the same spot. But that does not mean you cannot use the same zone. The abdomen, for instance, offers a large surface area, you can work methodically around it across many weeks before returning to any given point. The same applies to each thigh and each upper arm.

A practical approach many people use is to divide the abdomen into quadrants and move between them, then switch to a thigh or arm site for the next injection. Others simply alternate: abdomen one week, thigh the next, upper arm the week after. Either pattern is fine as long as no single spot is being used twice in close succession.

If you want to make sure you are choosing the most effective location each time, our guide on where to inject Mounjaro walks through each approved site in detail. Keeping a record of both the day and the site simplifies things considerably.

Does where you store tirzepatide affect how you should inject it?

Yes, in a practical sense. Tirzepatide is stored in the refrigerator, and injecting a cold pen can make the injection mildly uncomfortable. Allowing the pen to sit at room temperature for a short time before use (always within the window stated in your Patient Information Leaflet, never exceeding it) can reduce that sensation.

Injecting cold medicine into already-sensitive skin is one of those things people notice more than they expect. It rarely causes any harm, but it is easy to avoid. Details on exactly how long the pen can safely be kept outside the fridge are in our guide to tirzepatide storage, since the precise room-temperature limit is product-specific and changes between pens and conditions.

After each injection, dispose of the used needle safely. A sharps container is the correct way to do this, loose needles in household bins are a safety risk. Replacing the needle between injections is also part of good technique; blunt needles cause more discomfort and may affect the skin over time. Fresh alcohol swabs for cleaning the site before each injection are another small step that reduces infection risk at the site.

Tirzepatide is the active ingredient in Mounjaro, the only dual GIP and GLP-1 receptor agonist licensed in the UK for weight management. Understanding the practical side of administering it properly is part of getting the most from the treatment. If you have questions about whether tirzepatide is clinically suitable for you, you can check your eligibility with our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, not a piece of software.